TuHURA Biosciences, Inc. Common Stock (HURA) is a publicly traded Healthcare sector company. As of May 21, 2026, HURA trades at $2.41 with a market cap of $162.39M and a P/E ratio of -3.82. HURA moved -3.25% today. Year to date, HURA is +225.08%; over the trailing twelve months it is -35.75%. Its 52-week range spans $0.41 to $7.93. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces HURA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent politician trading activity in HURA includes disclosures from Laurel Lee, Laurel Lee, and Laurel Lee. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
| Metric | Value |
|---|---|
| Price | $2.41 |
| Market Cap | $162.39M |
| P/E Ratio | -3.82 |
| EPS | $-0.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.93 |
| 52-Week Low | $0.41 |
| Volume | 564.89K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-30.05M |
| Gross Margin | 0.00% |
3 analysts cover HURA: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.